Journal of the American College of Cardiology
Quarterly Focus Issue: Prevention/OutcomeState-of-the-Art PaperTroponin Elevation in Heart Failure: Prevalence, Mechanisms, and Clinical Implications
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Kociol has received funding from an American Heart Association Pharmaceutical Roundtable outcomes traininggrant (0875142N). Dr. Pang has served as a consultant for Astellas, Bayer, EKR Therapeutics, Johnson & Johnson, The Medicines Company, Otsuka, Palatin Technologies, PDL BioPharma, Pericor Therapeutics, and Solvay Pharmaceuticals; has received honoraria from BiogenIdec, Corthera, Ikaria, and Nile Therapeutics; and has received research support from Merckand PDL BioPharma. Dr. Gheorghiade has served as a consultant for Abbott Laboratories, Astellas, AstraZeneca, Bayer Schering Pharma AG, CorThera, Cytokinetics, DebioPharm S.A., Errekappa Terapeutici, GlaxoSmithKline, Ikaria, Johnson & Johnson, Medtronic, Merck, Novartis Pharma AG, Otsuka Pharmaceuticals, Palatin Technologies, Pericor Therapeutics, Protein Design Laboratories, Sanofi-Aventis, Sigma Tau, Solvay Pharmaceuticals, and Trevena Therapeutics; and has received significant (>$10,000) support from Bayer Schering Pharma AG, DebioPharm S.A., Medtronic, Novartis Pharma AG, Otsuka Pharmaceuticals, Sigma Tau, Solvay Pharmaceuticals, and Pericor Therapeutics. Dr. Fonarow has received research support from the National Heart, Lung, and Blood Institute; consulting fees from GlaxoSmithKline, Medtronic, Novartis, and Scios; and honoraria from GlaxoSmithKline and Medtronic. Dr. O'Connor has received research support from the National Institutes of Healthand Roche Diagnostics; and has served as a consultant for Merck, Medtronic, Forest, GE Healthcare, Amgen, Medpace, Actelion, Johnson & Johnson, Novella, Roche Diagnostics, and Trevena. Dr. Felker has received research support from Roche Diagnostics, BG Medicine, Otsuka, and Cytokinetics; and consulting fees from Corthera, Amgen, Cytokinetics, and XDX.